Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Genprex Inc (NQ: GNPX )

3.090 USD +0.040 (+1.31%)
Official Closing Price Updated: 4:36 PM EST, Nov 27, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Genprex Inc

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Company’s Milestone Achievements
From GlobeNewswire News Releases
Record Revenues, Milestone Achievements Indicate Strength, Potential of Biotech Sector
NetworkNewsWire Editorial Coverage 
From PR Newswire
Genprex to Present at the RHK Capital 4th Annual Disruptive Growth Conference
Genprex will present at upcoming conference in New York City on September 4, 2019. 
From Business Wire News Releases
Genprex Demonstrates Growth and Expansion Through Recent Achievements
Genprex announces recent achievements since its IPO 
From Business Wire News Releases
Genprex™ Manufacturing Partner Aldevron Completes Significant Step in Manufacturing for Oncoprex™ Clinical Development Program
Genprex Announces the Completion of Plasmid DNA Manufacturing by Partner, Aldevron 
From Business Wire News Releases
Genprex Begins Next Phase of Drug Branding Program
Genprex Submits Non-proprietary Drug Name Selections to USAN Council. 
From Business Wire News Releases
The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags WVE IRWD MEDP
From Benzinga
Genprex Provides Update on Development of its Oncoprex Immunogene Therapy in Combination with Immunotherapy for Non-Small Cell Lung Cancer
Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company, today provided an update on development of its lead drug candidate, Oncoprex™ immunogene therapy, in combination with immunotherapy... 
From Business Wire News Releases
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Gene Therapy as Potential Cancer Treatment
via NetworkNewsAudio – Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “Biotechs That Successfully Combat Cancer Could See Blockbuster Returns.” 
From GlobeNewswire News Releases
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Hunt for Gene Therapy Breakthroughs
via NetworkWire — Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and... 
From GlobeNewswire News Releases
Biotechs That Successfully Combat Cancer Could See Blockbuster Returns
NetworkNewsWire Editorial Coverage 
From PR Newswire
Genprex to Present at Sachs 5th Annual Immuno-Oncology BD&L and Investment Forum
Genprex to Present at Sachs Conference in Chicago on May 31, 2019 
From Business Wire News Releases
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Promising New Gene Therapies
via NetworkNewsAudio – Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “New Gene Therapies Hold Out Promise for Patients.” 
From GlobeNewswire News Releases
Genprex Retains Addison Whitney for Drug Nomenclature Branding
Genprex Selects Addison Whitney for Drug Naming Agency. 
From Business Wire News Releases
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Gene Therapies for Cancer Treatment
via NetworkWire — Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and... 
From GlobeNewswire News Releases
New Gene Therapies Hold Out Promise for Patients
NetworkNewsWire Editorial Coverage 
From PR Newswire
Genprex (GNPX) Featured in NetworkNewsAudio Broadcast Discussing Gene Therapy Programs on the Cusp of Curing the Incurable
via NetworkNewsAudio -- Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio broadcast titled, “Potential Blockbuster Gene Therapy Programs to Watch in 2019.” 
From GlobeNewswire News Releases
Genprex Featured in NetworkNewsAudio Broadcast on Potential Gene Therapy Treatment for Cancer
From Newsfile Corp News Releases
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Cancer and Gene Therapy Treatment
via NetworkWire — Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and... 
From GlobeNewswire News Releases
Genprex (GNPX) Featured in NetworkNewsWire Publication about Revolutionary Gene Therapies
From Newsfile Corp News Releases
Potential Blockbuster Gene Therapy Programs to Watch in 2019
NetworkNewsWire Editorial Coverage 
From PR Newswire
Genprex Collaborators Report Positive TUSC2 and Checkpoint Blockade Preclinical Data at the 2019 AACR Annual Meeting
Genprex Collaborators Announce New Preclinical Data at AACR 
From Business Wire News Releases
Genprex Provides Clinical, Corporate, and Financial Update for the Year Ending December 31, 2018
Genprex Announces Fourth Quarter Results and Year-End Update 
From Business Wire News Releases
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Advanced Medical Cancer Therapy
via NetworkNewsAudio – Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “Advanced Medical Technologies Provides Unprecedented Targeting in Cancer... 
From GlobeNewswire News Releases
Genprex Featured in NetworkNewsAudio Publication on Unprecedented Targeting in Cancer Treatment
From Newsfile Corp News Releases
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Innovative Cancer Treatments
via NetworkWire — Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and... 
From GlobeNewswire News Releases
Genprex Featured in NetworkNewsWire Publication on Innovations in Cancer Therapy
From Newsfile Corp News Releases
Advanced Medical Technologies Provide Unprecedented Targeting in Cancer Therapy
NetworkNewsWire Editorial Coverage 
From PR Newswire
Genprex Inc. Discusses Plans to Expand Clinical Trials in Fight Against Cancer in Exclusive Audio Interview with NetworkNewsWire
via NetworkWire – NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community, today announces... 
From GlobeNewswire News Releases
NetworkNewsAudio Announces Audio Press Release (APR) on Genprex Inc.'s Transformative Work in Gene Therapy
From Newsfile Corp News Releases
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.